Hypothesis-generating for Ebstein anomaly management; leaves open need for prospective trials in this rare CHD.
Ebstein anomaly accounts for <1% of all congenital heart defects (CHDs), with a prevalence of ~1 per 200,000 live births. In 1866, Wilhelm Ebstein described “A very rare case of insufficiency of the tricuspid valve, caused by a severe congenital malformation”.
No takes yet. Share an insight, caveat, or question.
Waldmann et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: